ARCIS BIOTECHNOLOGY
Arcis Biotechnology is focused on providing fast and convenient nucleic acid sample prep solutions. Obtaining genetic material from biological samples is a critical step which is often a time consuming and inefficient process. In less than 3 minutes with no prior sample preparation the Arcis DNA Prep range of products allow users to quickly and conveniently go from cellular material to downstream nucleic acid investigation without the need for traditional isolation or purification. The process requires no laboratory equipment and requires as little as 30µl of blood as a starting material. Arcis DNA products can be used on many different samples containing DNA including whole blood, plasma, urine, buccal swabs, and hair follicles .
ARCIS BIOTECHNOLOGY
Industry:
Biotechnology Health Care Life Science Medical Pharmaceutical
Founded:
2009-01-01
Address:
Warrington, Warrington, United Kingdom
Country:
United Kingdom
Website Url:
http://www.arcisbio.com
Total Employee:
1+
Status:
Active
Total Funding:
6.6 M GBP
Technology used in webpage:
Domain Not Resolving Person Schema Facebook Sharer Gravatar Profiles CrUX Top 50m CrUX Dataset Pinterest Reddit
Similar Organizations
Exprimo
Exprimo is focuses on the application of population PK, advanced PK/PD and drug-disease modelling & simulation.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Current Advisors List
Current Employees Featured
Founder
Investors List
Capital Cell
Capital Cell investment in Venture Round - Arcis Biotechnology
Fund Twenty8
Fund Twenty8 investment in Equity Crowdfunding - Arcis Biotechnology
Calculus Capital
Calculus Capital investment in Seed Round - Arcis Biotechnology
Calculus Capital
Calculus Capital investment in Seed Round - Arcis Biotechnology
Official Site Inspections
http://www.arcisbio.com
- Host name: 172.67.213.18
- IP address: 172.67.213.18
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Arcis Biotechnology"
About Us - Arcus Biosciences
Arcus Biosciences - Crunchbase Company Profile
Contact Email [email protected] Phone Number +1 510-694-6200 Arcus Biosciences is an oncology-focused clinical-stage biopharmaceutical company …See details»
Arcus Biosciences - LinkedIn
Arcus Biosciences is a rapidly growing, clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines that may have the potential to help people ...See details»
Arcus Biosciences - businessabc
1 day ago Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, …See details»
Arcus Biosciences - Arcus Biosciences Appoints Richard Markus, …
Jan 21, 2025 Dr. Markus will oversee Arcus’s clinical development organization and portfolio that includes seven clinical-stage programs with multiple ongoing Phase 3 studies Arcus …See details»
Arcus Biosciences Overview | SignalHire Company Profile
Arcus Biosciences is a rapidly growing, clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines that may have the potential to …See details»
Leadership Team - Arcus Biosciences
After several years as a member of the Arcus Scientific Advisory Board, in 2020 Dr. Yingling joined Arcus as Senior Vice President, Research. As a member of the Research Leadership team, Dr. Yingling provides guidance to all aspects …See details»
Arcus Biosciences to Present First Combination Data for HIF-2a ...
Apr 23, 2025 Founded in 2015, the company has expedited the development of multiple investigational medicines into clinical studies, including new combination approaches that …See details»
Board of Directors - Arcus Biosciences
During his 17-year tenure at Amgen, Dr. Lacey oversaw Amgen’s Discovery Research organization during a key period in the company’s history, leading more than 1,200 scientists across a portfolio of drug discovery and development …See details»
Arcus Biosciences - Arcus Biosciences Reports Second-Quarter …
Aug 8, 2024 To access the call, please dial (404) 975-4839 (local) or (833) 470-1428 (toll-free), using Access Code: 287576. To access the live webcast and accompanying slide …See details»
ARC-19 Lay Summary - trials.arcusbio.com
If you have any questions about this study, please contact us at: [email protected] Organization Website Use the study identifier Arcus …See details»
Arcus Biosciences Retains Rights to Casdatifan, a Potential
Feb 18, 2025 Founded in 2015, the company has expedited the development of multiple investigational medicines into clinical studies, including new combination approaches that …See details»
Find A Cancer Clinical Trial | Arcus Trials
Find out about current and upcoming clinical trials from Arcus. Our trials include studies such as lung cancer, gastrointestinal cancer and more.See details»
Arcus Biosciences - Arcus Biosciences Reports Fourth-Quarter and …
Feb 25, 2025 HAYWARD, Calif.--(BUSINESS WIRE)-- Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated …See details»
Scientific Advisory Board - Arcus Biosciences
During his 17-year tenure at Amgen, Dr. Lacey oversaw Amgen’s Discovery Research organization during a key period in the company’s history, leading more than 1,200 scientists …See details»
Arcus Founders Talk Strategy and Legacy | Arcus Biosciences
The company is confident in its strategy to date and is now focused on building a long-term independent and commercial organization. “As we look back on the choices we made five or …See details»
Arc Institute Teams with 10x and Ultima Genomics to Evolve …
Apr 28, 2025 “I don’t think people understand quite how complex a cell is, the scale that will be needed, and how incredibly impactful it will be when it’s solved,” Gilad Almogy, PhD, co …See details»
ARCUS CHIEF MEDICAL OFFICER TRANSITIONS TO ROLE AT …
Biosciences, please visit www.arcusbio.com or follow us on Twitter. Investor Inquiries: Katherine Bock VP Investor Relations & Corporate Strategy (510) 694-6231 [email protected] Media …See details»
Arcus Biosciences - Arcus Biosciences to Present New Data from ...
Feb 10, 2025 New data from ARC-20, a Phase 1/1b study of the HIF-2a inhibitor casdatifan in clear cell renal cell carcinoma (ccRCC), will be presented in a rapid oral session by Dr. Toni …See details»
Arcus Biosciences - Arcus Biosciences Appoints Internationally ...
Oct 28, 2019 Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer therapies, today announced that Antoni …See details»